2025 IBD Pharmacist Virtual Symposium
Update on Pouchitis Management: Current Strategies and Emerging Therapies
Edward L. Barnes, MD, MPH
Katie Dunleavy, MB, BCh, BAO
The Future of IBD Therapy: Expert Perspectives on Biosimilars
Alan C. Moss, MD, FACG, FEBG, AGAF, FRCPI
Ross M. Maltz, MD
Melissa Kirkpatrick, PharmD, BCACP
Complicated Crohn’s Disease Cases: Perianal Disease, Intra-abdominal Abscess, & Strictures
David A. Schwartz, MD
Ira Leeds, MD, FACS, FASCRS
Medical Management & Therapeutic Drug Monitoring
Sushila Dalal, MD
Surgical Management of Inflammatory Bowel Disease
Michele Rubin, APN, CNS, CGRN
Health Maintenance (Pediatric)
Maureen Kelly, MS, RN, CPNP
The Role of the RD in IBD Clinic
Lauren Bintz, RD, CDN
Panel Discussion - Collins, Ferrari
Angelina Collins, MSN, ANP-BC
Melissa J. Ferrari, PA-C, MPAS
Scripps Conference: New Advances in Inflammatory Bowel Disease
Case Presentation: Inpatient IBD – My Approach to Management of Intra-Abdominal Abscesses
Benjamin L. Cohen, MD
PROactive isn’t PRO-science: When scientists go rogue!
Siddharth Singh, MD
Perioperative Optimization of the IBD Patient
Jonathan Worsey, MD, FACS, FRCS
Intestinal Ultrasound for Inflammatory Bowel Disease Monitoring
Marla C Dubinsky, MD
Patient Perspective on Decision-Making in IBD
McKenna Plant
DEBATE: To Do Proactive Therapeutic Drug Monitoring or Not?
Ryan W. Stidham, MD, MSc
Panel Discussion- Cohen, Dubinsky, Santillan
Cynthia Santillan, MD
Loading...
We're glad to see you're enjoying Crohn's Colitis Professional… but how about a more personalized experience?
Press cancel to remain on Crohn's Colitis Professional. Press the link below or the continue button to keep going.